Status:
UNKNOWN
Proflaxis Using Hydroxychloroquine Plus Vitamins-Zinc During COVID-19 Pandemia
Lead Sponsor:
Istinye University
Conditions:
Pneumonitis
Coronavirus Infection
Eligibility:
All Genders
20-90 years
Brief Summary
Healthcare professionals mainly doctors, nurses and their first degree relatives (spouse, father, mother, sister, brother, child) who have been started hydroxychloroquine(plaquenil) 200mg single dose ...
Detailed Description
Healthcare professionals mainly doctors, nurses and their first degree relatives (spouse, father, mother, sister, brother, child) who have been started hydroxychloroquine(plaquenil) 200mg single dose ...
Eligibility Criteria
Inclusion
- person who are working as health professional with contact to known COVID positive case
- Their first degree relatives (child, spouse or parents)
- must be able to swallow tablets
Exclusion
- Already using plaquenil for other reasons (RA etc)
- person with the diagnosis of COVID infection
- Person with the condition may cause complications with this medication (severe CVD, av block, already has ophtalmological complications, organ failure of any degree etc).
- Documented allergic history to chloroquine;
- Documented history of hematological system diseases;
- Documented history of chronic liver and kidney diseases;
- Documented history of cardiac arrhythmia or chronic heart diseases;
- Documented history of retina or hearing dysfunction;
- Documented history of mental illnesses; 10. Use of digitalis due to the previous disease.
Key Trial Info
Start Date :
March 20 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2020
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04326725
Start Date
March 20 2020
End Date
September 1 2020
Last Update
July 28 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istinye University Medical School
Istanbul, Turkey (Türkiye), 34010